Avery D. Posey
9Patents
2h-index
21Co-inventors
47Inventor score
Filing activity: Feb 22, 2013 → Mar 28, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9783591B2 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Chemistry; Metallurgy | 20 | Active |
| US10501519B2 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Chemistry; Metallurgy | 3 | Active |
| US11090336B2 | Tn-MUC1 chimeric antigen receptor (CAR) T cell therapy | Chemistry; Metallurgy | 2 | Active |
| US11597754B2 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Chemistry; Metallurgy | 2 | Active |
| US11673964B2 | Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias | Chemistry; Metallurgy | 1 | Active |
| US11535662B2 | CD28 compositions and methods for chimeric antigen receptor therapy | Chemistry; Metallurgy | 0 | Active |
| US11459390B2 | Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12234274B2 | Use of the CD2 signaling domain in second-generation chimeric antigen receptors | Chemistry; Metallurgy | 0 | Active |
| US12227588B2 | Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against T cell lymphomas and leukemias | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.